BiotechTube
DNTOX

DNTOX

Berlin, Germany· Est.
dntox.de
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

DNTOX is a pioneering contract research organization (CRO) at the forefront of next-generation, animal-free neurotoxicity testing. Leveraging advanced human-based in vitro models and standardized analysis workflows, the company generates reliable data for compound screening, hazard identification, and regulatory decision-making. Its services are aligned with emerging OECD standards, positioning it to capitalize on the global shift away from animal testing. With a strong scientific team and a clear focus on the complex human nervous system, DNTOX serves as a specialized partner for industries requiring sophisticated neurotoxicological safety assessments.

Toxicology

Technology Platform

Advanced human-based, multicellular, and multiplexed 2D & 3D in vitro test systems for modeling neurodevelopmental and neurofunctional processes, integrated with transcriptomic profiling (RNA-seq) and bioinformatics analysis.

Opportunities

The global regulatory drive to eliminate animal testing, especially in the EU for cosmetics and chemicals (REACH), creates a large, mandated market for human-relevant alternatives.
The upcoming formal adoption of an OECD guideline for DNT testing could establish DNTOX's methods as a regulatory standard, driving significant demand from chemical, pharmaceutical, and agrochemical companies required to comply.

Risk Factors

Growth is heavily dependent on the pace and final acceptance of its specific test methods by global regulatory agencies.
The company operates in a competitive niche and faces scientific risk if its complex in vitro models fail to predict human in vivo outcomes accurately, which could damage its credibility and commercial prospects.

Competitive Landscape

DNTOX competes in the niche of specialized neurotoxicity testing against other focused CROs (e.g., NeuroProof GmbH) and broader in vitro toxicology service providers. It also faces competition from academic consortia developing alternative methods and from large, diversified CROs that may offer similar services as part of a larger portfolio. Its differentiation lies in its deep focus on the nervous system and its alignment with upcoming OECD standards.

More companies in Neuroscience & CNS →More companies in Germany →